From Academic Research to $3.0M in Commercial Sales
A West-Coast US university research institute developed a breakthrough high-throughput x-ray crystallography screening technology. Despite its scientific potential, the venture lacked a commercial framework, a defined 12-month plan, and the necessary leadership to transition from a laboratory project to a market-ready company.
The Situation
A west-coast US-based university spinout, part of a high caliber research institute, had spun out a commercial company providing unique x-ray-based structural data for biopharma companies.
In being introduced to the client, Spectre Global Advisors Global Advisors asked key questions about developing the spinout’s 12-month plan and first five major milestones. We helped the board and investors identify what would be meaningful for them to see and why.
Spectre Global Advisors Global Advisors adised the company for two years, including in providing an interim CEO to establish the startup, hire the full-time team, develop and promote their commercial offerings and maret presence and realize the first $3.0M of commercial sales.
The Questions That Mattered
- What are the first five major milestones that will define commercial success?
- What do the board and investors need to see to ensure long-term commitment?
- How should the startup’s initial commercial offerings be structured for biopharma clients?
- What leadership and team composition are required to move from research to revenue?
Our Approach
Strategic Roadmap & Milestone
Provided an interim CEO to establish the startup’s operational foundation, allowing the technical founders to focus on product excellence while we built the business.
Interim Executive Leadership
Provided an interim CEO to establish the startup’s operational foundation, allowing the technical founders to focus on product excellence while we built the business.
Commercial Offering Development
Developed and promoted the company’s unique x-ray-based structural data offerings, ensuring they resonated with the needs of global biopharma R&D departments.
Full-Scale Team Recruitment
Led the hiring of a permanent, full-time professional team to ensure a seamless transition from a guided startup to an independent commercial leader.
Execution in Action
- Defined a rigorous 12-month operational plan and financial roadmap.
- Spearheaded market presence and business development activities for two years.
- Managed the end-to-end recruitment process for the executive and technical staff.
- Facilitated the transition from interim management to a permanent leadership structure.
Outcomes
- $3.0M in commercial sales achieved during the initial two-year advisory period.
- Successful transition to a high-performing, full-time professional team.
- Established a clear, market-ready commercial presence within the biopharma sector.
- Strengthened investor confidence through the achievement of all five key milestones.
Why This Matters
Translating high-caliber research into a commercial success story requires more than just capital; it requires a disciplined roadmap and the right leadership at the start. This engagement illustrates how strategic milestones and interim expertise can accelerate the journey from a laboratory breakthrough to a multi-million dollar commercial entity.
Let’s Ask the Right Questions
We partner with leaders operating where science, technology, and capital converge. Stay informed or start a confidential discussion.